GSK Plc (GLAXF)
GSK Market Cap : 121.00B for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 226.72M |
| Adaptimmune Therapeutics Plc | 6.891M |
| Biodexa Pharmaceuticals Plc | 1.015M |
| Oxford Biomedica Plc | 1.363B |
| NuCana Plc | 9.031M |
Market Cap Related Metrics
| PE Ratio | 16.46 |
| PS Ratio | 2.873 |
| PEG Ratio | 0.1252 |
| Price to Book Value | 5.493 |
| Price to Free Cash Flow | 21.57 |
| Price | 30.15 |
| Earnings Yield | 6.08% |
| PEGY Ratio | 0.1225 |
| Operating PE Ratio | 12.73 |
| Normalized PE Ratio | 15.25 |